Article Details
Retrieved on: 2021-07-20 15:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Alexion Pharmaceuticals, the therapy's developer, now plans to submit regulatory applications requesting approval of Ultomiris for gMG in the U.S., ...
Article found on: myastheniagravisnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here